A retrospective study examining the properties and characteristics of dementia patients in a palliative care center

A retrospective study examining the properties and characteristics of dementia patients in a palliative care center

Background/aim: The aim of this study is to evaluate why dementia patients (DPs) are admitted to a palliative care center (PCC) andwhich factors affect the length of stay (LOS) of DPs in the PCC, and to predict the course of the disease.Materials and methods: The files of DPs were scanned retrospectively in the PCC between 2013 and 2016. Data related to age, sex, LOS,symptoms, clinical conditions, comorbidities, and prognosis were recorded.Results: The study included 85 DPs with a mean age of 84.1 ± 6.7 years. LOS was determined as a median of 15.0 days. While LOSdecreased due to age and cancer, it increased due to pressure injury. Although mortality was increased by LOS, it was decreased byhypertension, mobilization, and percutaneous endoscopic gastrostomy. Among the DPs who were admitted to the PCC, the death ratewas 54.1% and the discharge rate was 45.9%.Conclusion: It is concluded that adopting a palliative care approach eases symptom management. While this approach decreases theburden of symptoms, it at the same time increases the quality of life of DPs and their families.

___

  • World Health Organization. Dementia: A Public Health Priority. Geneva, Switzerland: World Health Organization; 2012.
  • Prince M, Wimo A, Guerchet M, Ali GC, Wu YT, Prina M. World Alzheimer Report 2015: The Global Impact of Dementia: An Analysis of Prevalence, Incidence, Cost & Trends. London, UK: Alzheimer’s Disease International; 2015.
  • van der Steen JT, Radbruch L, Hertogh CM, de Boer ME, Hughes JC, Larkin P, Francke AL, Junger S, Gove D, Firth P et al. White paper defining optimal palliative care in older people with dementia: a Delphi study and recommendations from the European Association for Palliative Care. Palliat Med 2014; 28: 197-209.
  • Rexach L. Palliative care in dementia. Eur Geriatr Med 2012; 3: 131-140.
  • Hendriks SA, Smalbrugge M, Hertogh CM, van der Steen JT. Dying with dementia: symptoms, treatment, and quality of life in the last week of life. J Pain Symptom Manage 2014; 47: 710- 720.
  • Connor SR, Bermedo MCS. Global Atlas of Palliative Care at the End of Life. Worldwide Palliative Care Alliance. Geneva, Switzerland: World Health Organization; 2014.
  • Kydd A, Sharp B. Palliative care and dementia--A time and place? Maturitas 2016; 84: 5-10.
  • Dening T, Dening KH. Palliative care in dementia: does it work? Maturitas 2016; 83: 1-2.
  • Stern Y, Albert SM, Sano M, Richards M, Miller L, Folstein M, Albert M, Bylsma FW, Lafleche G. Assessing patient dependence in Alzheimer’s disease. J Gerontol 1994; 49: M216- 222.
  • Pinzon LC, Claus M, Perrar KM, Zepf KI, Letzel S, Weber M. Dying with dementia: symptom burden, quality of care, and place of death. Dtsch Arztebl Int 2013; 110: 195-202.
  • Klapwijk MS, Caljouw MA, van Soest-Poortvliet MC, van der Steen JT, Achterberg WP. Symptoms and treatment when death is expected in dementia patients in long-term care facilities. BMC Geriatr 2014; 14: 99.
  • Estabrooks CA, Hoben M, Poss JW, Chamberlain SA, Thompson GN, Silvius JL, Norton PG. Dying in a nursing home: treatable symptom burden and its link to modifiable features of work context. J Am Med Dir Assoc 2015; 16: 515- 520.
  • Mitchell SL, Teno JM, Kiely DK, Shaffer ML, Jones RN, Prigerson HG, Volicer L, Givens JL, Hamel MB. The clinical course of advanced dementia. N Engl J Med 2009; 361: 1529- 1538.
  • Oud L. Predictors of transition to hospice care among hospitalized older adults with a diagnosis of dementia in Texas: a population-based study. J Clin Med Res 2017; 9: 23-29.
  • Poblador-Plou B, Calderon-Larranaga A, Marta-Moreno J, Hancco-Saavedra J, Sicras-Mainar A, Soljak M, Prados-Torres A. Comorbidity of dementia: a cross-sectional study of primary care older patients. BMC Psychiatry 2014; 14: 84.
  • Ibrahim JE, Anderson LJ, MacPhail A, Lovell JJ, Davis MC, Winbolt M. Chronic disease self-management support for persons with dementia, in a clinical setting. J Multidiscip Healthc 2017; 10: 49-58.
  • Eriksson S, Gustafson Y, Lundin-Olsson L. Characteristics associated with falls in patients with dementia in a psychogeriatric ward. Aging Clin Exp Res 2007; 19: 97-103.
  • Campbell SE, Seymour DG, Primrose WR. A systematic literature review of factors affecting outcome in older medical patients admitted to hospital. Age Ageing 2004; 33: 110-115.
  • Meier DE, Ahronheim JC, Morris J, Baskin-Lyons S, Morrison RS. High short-term mortality in hospitalized patients with advanced dementia: lack of benefit of tube feeding. Arch Intern Med 2001; 161: 594-599.
  • Flattau A, Blank AE. Risk factors for 90-day and 180-day mortality in hospitalised patients with pressure ulcers. Int Wound J 2014; 11: 14-20.
  • Fulton AT, Rhodes-Kropf J, Corcoran AM, Chau D, Castillo EH. Palliative care for patients with dementia in long-term care. Clin Geriatr Med 2011; 27: 153-170.
  • Paganini-Hill A. Hypertension and dementia in the elderly: the leisure world cohort study. Int J Hypertens 2012; 2012: 205350.
  • Peters R, Beckett N. Hypertension, dementia, and antihypertensive treatment: implications for the very elderly. Curr Hypertens Rep 2009; 11: 277-282.
  • Suzuki Y, Urashima M, Izumi M, Ito Y, Uchida N, Okada S, Ono H, Orimo S, Kohri T, Shigoka H et al. The effects of percutaneous endoscopic gastrostomy on quality of life in patients with dementia. Gastroenterology Res 2012; 5: 10-20.
  • Murphy LM, Lipman TO. Percutaneous endoscopic gastrostomy does not prolong survival in patients with dementia. Arch Intern Med 2003; 163: 1351-1353.
Turkish Journal of Medical Sciences-Cover
  • ISSN: 1300-0144
  • Yayın Aralığı: 6
  • Yayıncı: TÜBİTAK
Sayıdaki Diğer Makaleler

The impact of plasma SOCS3 levels and endometrial leukocytes on unexplained infertility

Mehmet ŞİMŞEK, Nusret AKPOLAT, Derya DEVECİ, Hüseyin TİMURKAN, Zehra Sema ÖZKAN

Hamdi Cihan EMEKSİZ, Aysun BİDECİ, Burçin NALBANTOĞLU, Ayşin NALBANTOĞLU, Cem ÇELİK, Yasemin YULAF, Mahmut Orhun ÇAMURDAN, Peyami CİNAZ

Saliva levels of caspase-1, TNF-α, and IFN-γ in primary Sjögren’s syndrome: oral mucosal abnormalities revisited

Özgün ÖZÇAKA, Esin ALPÖZ, Gonca KARABULUT, Yasemin KABASAKAL, Gökhan KESER, Sercan GÜCENMEZ, Hayriye KOÇANAOĞULLARI, Gül KİTAPÇIOĞLU, Ayşe NALBANTSOY

Dr Munir Ahmad BHINDER, Muhammad Yasir ZAHOOR, Haleema SADIA, Muhammad QASIM, Rukhsana PERVEEN, Ghulam Murtaza ANJUM, Muhammad IQBAL, Najeeb ULLAH, Waseem SHEHZAD, Muhammad TARIQ, Ali Muhammad WARYAH

Filiz ÖZEL, Aynur Esen TÜREYEN, Fisun Şenuzun AYKAR, Gökhan KESER

Ankaferd Blood Stopper with antibiofilm potential successfully inhibits the extracellular matrix degradation enzymes and promotes wound healing of 3T3 fibroblasts in vitro

Tuba BAYGAR, Nurdan SARAÇ, Aysel UĞUR, Rukiye BORAN

Oğuzhan Fatih BALTACI, Şeyma ÇOLAKOĞLU, Gökçe Güllü AMURAN, Neslihan AYDIN, Mehmet SARĞIN, Arzu Karabay KORKMAZ, Mehmet Temel YILMAZ, Ergül BERBER

Ebru Ozan SANHAL, Hande ARSLAN

Serum vasohibin-1 and suppression of tumorigenicity-2 levels in children with predialysis chronic kidney disease

Nuran ÇETİN, Nadide Melike SAV

Serum S100B, NSE, and GRIA1 levels as neurological biomarkers in lead exposure

Ömer Hınç YILMAZ, Engin TUTKUN, Müjgan ERCAN, Sevilay SEZER, Esra FIRAT OĞUZ, Fatma Meriç YILMAZ